Target Price | €60.84 |
Price | €46.97 |
Potential | 29.53% |
Number of Estimates | 19 |
19 Analysts have issued a price target Siemens Healthineers 2026 . The average Siemens Healthineers target price is €60.84. This is 29.53% higher than the current stock price. The highest price target is €75.00 59.68% , the lowest is €50.00 6.45% . | |
A rating was issued by 20 analysts: 18 Analysts recommend Siemens Healthineers to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2026 of 29.53% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
18 Analysts have issued a sales forecast Siemens Healthineers 2025 . The average Siemens Healthineers sales estimate is €23.6b . This is 2.18% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €23.9b 3.19% , the lowest is €23.4b 1.07% .
This results in the following potential growth metrics:
2024 | €22.4b | 3.15% |
---|---|---|
2025 | €23.6b | 5.74% |
2026 | €25.0b | 5.75% |
2027 | €26.6b | 6.19% |
2028 | €28.4b | 6.95% |
2029 | €30.1b | 5.85% |
17 Analysts have issued an Siemens Healthineers EBITDA forecast 2025. The average Siemens Healthineers EBITDA estimate is €4.8b . This is 10.60% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.3b 20.02% , the lowest is €4.5b 3.22% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €4.0b | 9.30% |
---|---|---|
2025 | €4.8b | 20.28% |
2026 | €5.3b | 10.17% |
2027 | €5.9b | 10.38% |
2028 | €6.6b | 12.68% |
2029 | €7.0b | 5.68% |
2024 | 18.03% | 5.96% |
---|---|---|
2025 | 20.51% | 13.76% |
2026 | 21.37% | 4.19% |
2027 | 22.21% | 3.93% |
2028 | 23.40% | 5.36% |
2029 | 23.36% | 0.17% |
12 Siemens Healthineers Analysts have issued a net profit forecast 2025. The average Siemens Healthineers net profit estimate is €2.3b . This is 8.11% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.4b 13.28% , the lowest is €2.1b 0.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | €1.9b | 28.69% |
---|---|---|
2025 | €2.3b | 16.29% |
2026 | €2.6b | 16.26% |
2027 | €3.0b | 13.84% |
2028 | €3.4b | 14.88% |
2029 | €3.9b | 13.73% |
2024 | 8.68% | 24.76% |
---|---|---|
2025 | 9.55% | 9.97% |
2026 | 10.50% | 9.95% |
2027 | 11.26% | 7.24% |
2028 | 12.09% | 7.37% |
2029 | 12.99% | 7.44% |
12 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers EPS is €2.01 . This is 8.06% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.11 13.44% , the lowest is €1.85 0.54% .
This results in the following potential growth metrics and future valuations:
2024 | €1.73 | 29.10% |
---|---|---|
2025 | €2.01 | 16.18% |
2026 | €2.34 | 16.42% |
2027 | €2.67 | 14.10% |
2028 | €3.06 | 14.61% |
2029 | €3.48 | 13.73% |
Current | 25.22 | 22.01% |
---|---|---|
2025 | 23.29 | 7.63% |
2026 | 20.03 | 14.00% |
2027 | 17.60 | 12.13% |
2028 | 15.32 | 12.95% |
2029 | 13.47 | 12.08% |
Based on analysts' sales estimates for 2025, the Siemens Healthineers stock is valued at an EV/Sales of 2.77 and an P/S ratio of 2.18 .
This results in the following potential growth metrics and future valuations:
Current | 2.83 | 15.77% |
---|---|---|
2025 | 2.77 | 1.99% |
2026 | 2.62 | 5.44% |
2027 | 2.47 | 5.83% |
2028 | 2.31 | 6.50% |
2029 | 2.18 | 5.53% |
Current | 2.23 | 18.57% |
---|---|---|
2025 | 2.18 | 2.13% |
2026 | 2.06 | 5.43% |
2027 | 1.94 | 5.83% |
2028 | 1.82 | 6.50% |
2029 | 1.72 | 5.53% |
Siemens Healthineers...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
DZ BANK |
Hold
➜
Hold
|
Unchanged | Mar 24 2025 |
HSBC |
Buy
➜
Hold
|
Downgrade | Mar 23 2025 |
DAY BY DAY |
Sell
➜
Buy
|
Upgrade | Mar 23 2025 |
REDBURN ATLANTIC |
Buy
➜
Buy
|
Unchanged | Mar 21 2025 |
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Feb 27 2025 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
DZ BANK:
Hold
➜
Hold
|
Mar 24 2025 |
Downgrade
HSBC:
Buy
➜
Hold
|
Mar 23 2025 |
Upgrade
DAY BY DAY:
Sell
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Buy
➜
Buy
|
Mar 21 2025 |
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Feb 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.